This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / Business / MetrioPharm AG appoints Jürgen Braun
Business board appointment

MetrioPharm AG appoints Jürgen Braun

Analysis based on 6 articles · First reported May 26, 2026 · Last updated May 26, 2026

Sentiment
40
Attention
2
Articles
6
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The appointment of Jürgen Braun>>> to MetrioPharm AG>>>'s Scientific Advisory Board is a positive development for the company, potentially accelerating the clinical development of its lead compound MP1032>>>. This could lead to increased investor confidence in MetrioPharm AG>>>'s future prospects and its ability to bring new therapies to market.

biotechnology pharmaceuticals
Event Summary

MetrioPharm AG>>>, a Swiss clinical-stage biotechnology company, announced the appointment of Prof. Dr. med. Jürgen Braun>>> to its Scientific Advisory Board. Jürgen Braun>>> is an internationally recognized expert in rheumatology with over 800 peer-reviewed publications and numerous awards. His expertise will specifically enhance MetrioPharm AG>>>'s focus on inflammatory rheumatic diseases and the clinical strategy for its lead compound, MP1032>>>. Jürgen Braun>>> has been advising MetrioPharm AG>>> since December 2025, contributing significantly to the development of MP1032>>> in rheumatological indications. Both Thomas Christiansen>>>, CEO, and Steffen Stürzebecher>>>, CMO of MetrioPharm AG>>>, expressed enthusiasm for Jürgen Braun>>>'s addition, citing his extensive experience in clinical trials and rheumatology research. MP1032>>> is being developed as a self-regulating immunomodulator for inflammatory and infectious diseases, aiming to replace or reduce glucocorticoid use.

Entities Involved
priv
MetrioPharm AG
MetrioPharm AG benefits from the enhanced expertise in inflammatory rheumatic diseases by appointing Jürgen Braun>>> to its Scientific Advisory Board, which is expected to aid in the clinical development of MP1032.
Importance 100.0 Sentiment 50.0
per
Jürgen Braun
Jürgen Braun>>> joins the Scientific Advisory Board of MetrioPharm AG>>>, bringing extensive experience in rheumatology and clinical trials to support the development of MP1032.
Importance 90.0 Sentiment 30.0
oth
MP1032
MP1032>>> is the lead compound of MetrioPharm AG>>> for inflammatory and infectious diseases, and its development strategy will be further supported by the expertise of Jürgen Braun>>>.
Importance 80.0 Sentiment 40.0
per
Thomas Christiansen
Thomas Christiansen>>>, CEO of MetrioPharm AG>>>, expressed delight in welcoming Jürgen Braun>>> to the Scientific Advisory Board, highlighting the value of his expertise.
Importance 20.0 Sentiment 0.0
per
Steffen Stürzebecher
Steffen Stürzebecher>>>, CMO of MetrioPharm AG>>>, emphasized the invaluable experience Jürgen Braun>>> brings to the clinical trials for MP1032>>>.
Importance 20.0 Sentiment 0.0
ngo
German Society for Rheumatology
Jürgen Braun>>> is a member of the Advisory Board of the German Society for Rheumatology>>>.
Importance 10.0 Sentiment 0.0
ngo
Assessment of SpondyloArthritis International Society
Jürgen Braun>>> was a long-standing board member of Assessment of SpondyloArthritis International Society>>>.
Importance 10.0 Sentiment 0.0
alliance
European Union
The European Union>>> funded a Phase IIa study for MP1032>>> with 8 million euros.
Importance 5.0 Sentiment 0.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.